Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Survey of Chinese physicians on how they diagnose and manage fatty liver disease

Asks doctors in China about their views and practice on MASLD care.

Plain-language title generated from the registry record
Registry title: Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians

Key facts

Where
Beijing, ChinaSee the site

Where in China

  • BeijingBeijing, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Novo Nordisk A/S
Trial code
NCT07682363
Record updated
2 July 2026
Original description
This study is a cross-sectional survey-based study. The main goal of this study is to investigate the attitudes, perceptions, and clinical practice in assessing liver fibrosis following a metabolic dysfunction-associated steatotic liver disease (MASLD) diagnosis, and the management of MASLD patients among Chinese physicians in the departments of endocrinology / hepatology / infection / gastroenterology in Grade IIIA hospitals in provincial capitals or municipalities.Read full original descriptionShow less

Attitudes, Perceptions, Clinical Practice, and Barriers in Diagnosis and Management of Patients With Metabolic Dysfunction-associated Steatotic Liver Disease: a Cross-sectional Survey on Physicians in China

This study is a cross-sectional survey-based study. The main goal of this study is to investigate the attitudes, perceptions, and clinical practice in assessing liver fibrosis following a metabolic dysfunction-associated steatotic liver disease (MASLD) diagnosis, and the management of MASLD patients among Chinese physicians in the departments of endocrinology / hepatology / infection / gastroenterology in Grade IIIA hospitals in provincial capitals or municipalities.

Inclusion: Has provided informed consent; Registered clinical practice location in provincial capital or municipality; Physician with a license for clinical practice; Employed in the Department of Endocrinology, Hepatology, Infection or Gastroenterology; Hospital level: Grade IIIA hospital; Hold a professional title of associate chief physician or above, or senior attending physician (as an attending physician for more than or equal to (≥) 3 years); Conducts outpatient clinics for at least 1 half-days per week; The patient load of MASLD/MASH per month in the department should be:; a. Endocrinology ≥20 patients per month; b. Hepatology/Gastroenterology/ Infectious ≥30 patients per month.

Exclusion: -Participants will be excluded if they have unwillingness precluding adequate cooperation, fail to complete the questionnaire, or submit questionnaires verified as invalid.

ClinicalTrials.gov NCT07682363